2 Dividend Stocks to Hold for the Next 5 Years

By Keith Speights – Feb 19, 2026 at 3:45AM ESTKey PointsAbbVie is a Dividend King that's a successful player in multiple critical therapeutic areas.Enbridge is an energy infrastructure leader with an especially attractive dividend.We’re bullish on these 10 stocks ›NYSE: ENBEnbridgeMarket Cap$111BToday's Changeangle-down(-1.10%) $0.56Current Price$50.88Price as of February 18, 2026 at 3:58 PM ETIncome investors can rest easy owning these stocks.What will the world look like five years from now? How you answer the question should help you determine how you invest now. I expect that healthcare and energy will remain critical in 2031. That's why I think holding the following two dividend stocks for the next five years is a smart move for income investors. 1. AbbVie AbbVie (ABBV 1.71%) ranks as the world's third-largest healthcare company based on market cap. The company markets 12 blockbuster drugs, plus several others that generate hundreds of millions in annual sales. I predict that the three most important markets for AbbVie -- immunology, neuroscience, and oncology -- will expand significantly going forward. Populations in the U.S. and many other major countries are aging. As people age, they're more susceptible to developing autoimmune and neurological disorders as well as cancer. ExpandNYSE: ABBVAbbVieToday's Change(-1.71%) $-3.98Current Price$228.88Key Data PointsMarket Cap$404BDay's Range$226.08 - $234.0052wk Range$164.39 - $244.81Volume218KAvg Vol6.6MGross Margin83.38%Dividend Yield2.91% AbbVie has clearly demonstrated its ability to innovate internally and find outstanding acquisition targets in each of these areas. The company's prowess on these fronts enabled it to quickly return to growth after losing patent exclusivity for its longtime best-selling drug, Humira. Income investors should love AbbVie's dividend. The drugmaker is a member of the Dividend Kings, a group of stocks that have increased their dividends for at least 50 consecutive years. Its forward dividend yield of roughly 3% is also attractive. Image source: Getty Images. 2. Enbridge Would you bet more money that the U.S. will consume more oil and gas five years from now or that it will use less? The wise choice is to take the former bet rather than the latter. Enbridge (ENB 1.10%) is one of the best-positioned companies to profit from increased oil and gas usage. The company's pipelines transport roughly 30% of the crude oil produced in North America and 20% of the natural gas consumed in the U.S. It also ranks as the largest natural gas utility in the U.S. based on volume. ExpandNYSE: ENBEnbridgeToday's Change(-1.10%) $-0.56Current Price$50.88Key Data PointsMarket Cap$111BDay's Range$50.81 - $51.7252wk Range$39.73 - $54.20Volume238KAvg Vol4.6MGross Margin32.74%Dividend Yield5.38% Management has identified around $50 billion of growth opportunities through 2030. In particular, Enbridge projects strong natural gas demand in North America from industrial expansion and data centers. Those projections are trustworthy, in my view, especially considering that Enbridge's executive team has led the company to meet or beat financial guidance for 20 consecutive years. This stock is also an income investor's dream. Enbridge's forward dividend yield is 5.4%. The company has increased its dividend for 31 consecutive years. That streak is likely to continue well into the future, with Enbridge projecting average annual earnings and distributable cash flow growth of around 5% beyond 2026. Read NextFeb 15, 2026 •By Matt DiLalloThis Durable 5.2%-Yielding Dividend Stock is as Dependable as They ComeFeb 9, 2026 •By Reuben Gregg Brewer3 Ultra-High-Yield Energy Dividend Stocks to Buy and Hold for 2026Feb 5, 2026 •By Reuben Gregg BrewerCould Buying Enbridge Stock Today Set You Up for Life in Safe Dividend Income?Feb 5, 2026 •By Keith Speights3 High-Yield Energy Stocks to Buy in FebruaryJan 31, 2026 •By Reuben Gregg BrewerCould Owning This Energy Stock Today Change Your Financial Trajectory?Jan 28, 2026 •By Justin PopeCould Buying Enbridge Stock Today Set You Up for Life in Safe Dividend Income?About the AuthorKeith Speights is a contributing Motley Fool healthcare analyst covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, technology, and marijuana. Prior to The Motley Fool, Keith was CEO of Constant Care Technology, a healthcare technology company; vice president of American HealthTech, a healthcare software company; and a director of operations for Blue Cross Blue Shield of Mississippi, a health insurer. He holds a B.S. in Industrial Engineering from Mississippi State University.TMFFishBizStocks MentionedEnbridgeNYSE: ENB$50.88 (1.10%) $0.56AbbVieNYSE: ABBV$228.88 (1.71%) $3.98*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.